Alan B. Slifka Foundation
Slifka / Ritvo Innovation in Autism Research Award
Application Opens: January 28, 2020
Application Deadline: February 25, 2020 11:59 pm PT - CLOSED
Description: The Alan B. Slifka Foundation seeks to promote innovative research on autism spectrum disorder that will lead to novel treatments and improvements in the quality of life of individuals with autism, as well as novel discoveries regarding the basic science of autism. The Foundation wishes to partner with INSAR in honoring the most meritorious and innovative research ideas of junior investigators.
Award: The Foundation will provide one research award ($25,000): for either clinical research (diagnosis or treatment of autism or educational efforts) or basic research (epidemiology, genetics, neuroscience, immunology etc). Individuals must be current INSAR Full Members at the time of application. The awardee must submit a report to the Foundation and INSAR one year post-award. The awardee will be invited to present their results in an oral session at the INSAR Annual Meeting 2 years post-award.
Eligibility: Current Full Members of INSAR are eligible for this award. At the time of application, applicants must be within seven years of receipt of their PhD, MD, DO, EdD, etc (any advanced degree that allows a career in autism research). The member must have standing in a university, college or research institute that is capable of accepting and administering NIH (or equivalent in other countries) grants and must, therefore, have a faculty appointment.
The goal of the Slifka Award is to support promising junior investigators to pursue excellent research for which they do not have funding and are not likely to get funding readily. It is important that applicants clearly state what element of their work will be supported by the Slifka award and the status of existing and pending funds.
PLEASE NOTE: postdoctoral fellows are not eligible for this award.
Announcement: Recipients will be selected by the Scientific Standards Committee and a representative from the Slifka Foundation. The recipient of the Slifka/Ritvo Award will be recognized at the awards ceremony at the INSAR Annual Meeting. The awardee will be invited to present their results in an oral presentation at the annual meeting 2 years post-award.
SUBMISSION: The process for submitting an application is self nomination. The applicant must meet all of the eligibility requirements indicated below. The applicant should submit:
- A 1-2 page proposal of the research to be conducted through the award. Specify how the requested funds will enable significant activities that are distinct from ongoing work. Page limit is inclusive of statement of purpose, specific aim(s), background/significance, approach, expected findings and limitations and explanation of why other mechanisms would not currently support this proposal.
References beyond the 2 pages are permitted.
- Current other support, including amount and exact periods of funding, and specification of overlap with the submitted proposal. Please clarify how the award will not duplicate either current or institutional support, especially for studies building off of larger grants. Should be in NIH Other Support format.
- Budget and Budget justification
- NIH Biosketch
- The application documents must be combined as a single PDF document and uploaded through the online Slifka Award application form.
Terms of Award: The award will be made to and administered by the applicant’s institution. The award may be used to complete the research detailed in the proposal. The conditions from the Slifka Foundation stipulate that none of the funds can be used for indirect costs. Prior to receipt of the award, the award recipient will be required to present a short research plan and budget along with evidence of IRB approval to conduct research related to human subjects or IACUC approval related to animal subjects. The period of performance is for 12 months, September 1, 2020 – August 31, 2021.
By September 1, 2021, a report of progress must be submitted to the Alan B. Slifka Foundation and the International Society for Autism Research (firstname.lastname@example.org). The awardee will be invited to present their results in an oral session at the INSAR Annual Meeting 2 years post-award. For the 2020 awardee, the presentation request would be for INSAR 2022.
Questions: Direct any questions about the Slifka Award process to Jennifer Gentry (email@example.com).
Slifka / Ritvo Innovation in Autism Research Award
The Alan B. Slifka Foundation seeks to promote innovative research on autism spectrum disorders conducted by junior investigators. The purpose of the award is to lead to novel treatments and improvements in the quality of life of individuals with autism. The award was introduced in 2010. Past award winners are listed below.
|2017||Meng-Chuan Lai|| |
|| Oleksandr Shcheglovitov
|| Basic Science: Adam Naples
|| Clinical: Rosa Hoekstra
|| Basic Science: Lucina Uddin
|| Clinical: Dennis Wall
|| Basic Science: Carissa Cascio
|| Clinical: Carla Mazefsky
|| Basic Science: Judy Van De Water
| Clinical: Alicia Hall
Basic Science: Jeffrey Hutsler
| Clinical: Rhea Paul